Coal Sector has Crossed the One Billion Tonne Milestone for the Financial Year 2024-25
The cumulative coal production in FY 2024-25 has now crossed the One Billion Tonne (BT) mark, reaching 1047.57 (Provisional), compared to 997.83 MT in FY
Home
Page 339
India’s Electric Vehicle Sales Surpass One Million Mark in FY 2024-25
India’s electric mobility sector has achieved a significant milestone by surpassing one million electric vehicle (EV) sales in the financial year 2024-25. This surge is
NHAI Increases Toll Charges By 4-5% Nationwide To Fund Highway Expansion
The National Highways Authority of India (NHAI) has increased toll charges by 4 to 5 per cent nationwide. The hike, effective immediately, will help fund
Steel PSUs Observes ‘Swachhata Pakhwada’ from March 16-31, 2025
All PSUs and institutions under its administrative control of Steel Ministry , including SAIL, NMDC, RINL, KIOCL, MOIL, MECON, MSTC, NISST, JPC, and BPNSI, observed
NTPC records 438.6 BU of Total Generation, Up By 3.88% YOY
NTPC Ltd has demonstrated impressive growth in its operational performance during the financial year 2024-25, achieving a 3.88% increase in total power generation compared to
NHPC Commissions 3 Units (200 MW each) of 800 MW Parbati-II Hydroelectric Project
NHPC’s 800 MW Parbati-II Project (Himachal Pradesh) has achieved Commercial Operation of three of the four Units at 00:00 hrs on 01.04.2025. Commissioning of the
Rebuilding Lives, Restoring Hope: Kerala’s largest Rehabilitation Effort begins in Wayanad
Rebuilding communities with compassion: A new dawn for Wayanad Bengaluru – April 01, 2025: A new chapter of hope and resilience unfolded as the Government of
ICRA Ratings Upgrades Muthoottu Mini Financiers to ‘A Stable’
Sustained Growth, Profitability, and Asset Quality Drive Rating Upgrade Bengaluru, 01 April 2025: Muthoottu Mini Financiers Ltd., one of India’s leading NBFCs popularly known as Muthoottu
Gennova Advances Pathbreaking AI-Enhanced saRNA Vaccine for one of the deadliest known viruses in collaboration with CEPI
Gennova Biopharmaceuticals Ltd. expands collaboration with CEPI, securing up to US$13.38 million to accelerate the development of a vaccine against Nipah virus using the self-amplifying
Glenmark Pharmaceuticals Inc., USA launches Vancomycin Hydrochloride for Injection USP, 750 mg/vial, 1.25 g/vial and 1.5 g/vial (Single-Dose Vial)
Bengaluru, April 1, 2025: Glenmark Pharmaceuticals Inc., USA (Glenmark) announces the launch1 of Vancomycin Hydrochloride for Injection USP, 750 mg/vial, 1.25 g/vial and 1.5 g/vial (Single-dose vial).